Supplementary Figure S1 shows representative images of immunostaining for uPAR in NSCLC and CRC RAS mutated samples expressing strong positivity (score > 3) compared to RAS wild-type samples negative for uPAR expression. This evidence concerns the gene PLAUR and colorectal carcinoma.